Drug Pipeline

Leniolisib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
1
Recruiting
1
Phase 3
1
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05438407 Pediatric Patients Aged 4 to 11 Years With APDS APDS Active, Not Recruiting
Phase 2
NCT06990529 Long-term Safety and Efficacy of Leniolisib in PIDs With Immune Dysregulation PIDs Linked to PI3K Recruiting
NCT06897358 Leniolisib for Immune Dysregulation in CVID Common Variable Immunodeficiency (CVID) Active, Not Recruiting
NCT06549114 Leniolisib for Immune Dysregulation in PIDs Primary Immunodeficiency Disorders (PIDs) Active, Not Recruiting
Sponsors Running Leniolisib Trials
Get alerts when Leniolisib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free